4
Changes in Ownership
Enliven Therapeutics, Inc. Filed Acc 0000899243-23-006291
Director acquired 7,899,572 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC Director | 2023-02-23 | Grant or award | +7,611,458 | 8,661,225 | I | ||
| ORBIMED ADVISORS LLC Director | 2023-02-23 | Grant or award | +288,114 | 288,114 | I |
Loading xslF345X03/doc4.xml…